GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 767 filers reported holding GLAXOSMITHKLINE PLC in Q1 2021. The put-call ratio across all filers is 0.80 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $836,000 | +558.3% | 268,800 | +69.4% | 0.04% | +583.3% |
| Q1 2022 | $127,000 | -87.9% | 158,700 | +56.1% | 0.01% | -79.3% |
| Q4 2021 | $1,050,000 | -8.9% | 101,648 | -3.2% | 0.03% | -21.6% |
| Q3 2021 | $1,153,000 | +491.3% | 105,043 | -0.1% | 0.04% | +516.7% |
| Q2 2021 | $195,000 | -88.8% | 105,200 | -11.9% | 0.01% | -93.5% |
| Q1 2021 | $1,741,000 | +44.1% | 119,417 | +26.9% | 0.09% | +165.7% |
| Q4 2020 | $1,208,000 | +2416.7% | 94,072 | +224.4% | 0.04% | +1650.0% |
| Q3 2020 | $48,000 | -28.4% | 29,000 | -38.7% | 0.00% | -50.0% |
| Q2 2020 | $67,000 | -93.1% | 47,300 | -17.9% | 0.00% | -93.8% |
| Q1 2020 | $977,000 | +207.2% | 57,594 | -25.0% | 0.06% | +282.4% |
| Q4 2019 | $318,000 | +174.1% | 76,800 | +0.8% | 0.02% | +70.0% |
| Q3 2019 | $116,000 | +728.6% | 76,200 | +562.6% | 0.01% | +900.0% |
| Q2 2019 | $14,000 | -46.2% | 11,500 | -61.7% | 0.00% | -50.0% |
| Q1 2019 | $26,000 | -25.7% | 30,000 | +14.5% | 0.00% | -33.3% |
| Q4 2018 | $35,000 | -43.5% | 26,200 | -29.4% | 0.00% | -25.0% |
| Q3 2018 | $62,000 | +21.6% | 37,100 | +23.7% | 0.00% | +33.3% |
| Q2 2018 | $51,000 | -12.1% | 30,000 | -30.4% | 0.00% | 0.0% |
| Q1 2018 | $58,000 | +163.6% | 43,100 | -4.0% | 0.00% | +200.0% |
| Q4 2017 | $22,000 | +340.0% | 44,900 | +6.1% | 0.00% | – |
| Q3 2017 | $5,000 | -99.0% | 42,300 | -40.7% | 0.00% | -100.0% |
| Q2 2017 | $514,000 | -25.0% | 71,339 | -15.5% | 0.03% | -33.3% |
| Q1 2017 | $685,000 | -70.7% | 84,396 | -53.7% | 0.04% | -64.1% |
| Q4 2016 | $2,337,000 | +106.4% | 182,343 | +6.9% | 0.12% | +192.5% |
| Q3 2016 | $1,132,000 | -58.5% | 170,562 | -37.9% | 0.04% | -75.0% |
| Q2 2016 | $2,727,000 | +90800.0% | 274,844 | +1782.5% | 0.16% | – |
| Q1 2016 | $3,000 | -99.9% | 14,600 | -98.2% | 0.00% | -100.0% |
| Q4 2015 | $4,487,000 | +74683.3% | 797,412 | +4979.1% | 0.22% | – |
| Q3 2015 | $6,000 | -92.1% | 15,700 | -94.4% | 0.00% | -100.0% |
| Q2 2015 | $76,000 | -37.2% | 281,600 | -0.8% | 0.00% | -50.0% |
| Q1 2015 | $121,000 | -83.0% | 284,000 | +742.7% | 0.01% | -69.2% |
| Q4 2014 | $712,000 | -64.6% | 33,700 | -16.4% | 0.03% | -61.8% |
| Q2 2013 | $2,014,000 | – | 40,300 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JTC Employer Solutions Trustee Ltd | 6,324,319 | $241,621,000 | 32.36% |
| Black Creek Investment Management Inc. | 10,329,349 | $394,684,000 | 11.46% |
| Healthcare Value Capital, LLC | 100,000 | $3,821,000 | 7.54% |
| KAHN BROTHERS GROUP INC | 1,353,358 | $51,711,809,000 | 7.28% |
| EQUITY INVESTMENT CORP | 2,924,326 | $111,738,000 | 4.28% |
| Eversept Partners, LP | 1,503,700 | $57,456,377 | 3.99% |
| NKCFO LLC | 269,500 | $10,298,000 | 3.45% |
| Robinson Value Management, Ltd. | 96,990 | $3,706,000 | 3.31% |
| Keystone Financial Planning, Inc. | 237,691 | $9,082,000 | 3.30% |
| CLIFFORD CAPITAL PARTNERS LLC | 93,485 | $3,572,000 | 3.27% |